Given that we have found that restoring Drp1-mediated mitochondrial fission partially rescues locomotor defects in our model of HSP, it may lead us to consider whether Drp1 could be a potential therapeutic target for HSP or other neurodegenerative disorders. This evidence concerns the gene DNM1L and hereditary spastic paraplegia.